Literature DB >> 23700178

Prophylactic central lymph node dissection in differentiated thyroid cancer.

Julie A Goddard1, David L Steward.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23700178     DOI: 10.1007/s12020-013-9975-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  11 in total

1.  Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit.

Authors:  Wen T Shen; Lauren Ogawa; Daniel Ruan; Insoo Suh; Quan-Yang Duh; Orlo H Clark
Journal:  Surgery       Date:  2010-05-07       Impact factor: 3.982

Review 2.  Radioiodine treatment of well-differentiated thyroid cancer.

Authors:  Leonard Wartofsky; Douglas Van Nostrand
Journal:  Endocrine       Date:  2012-06-26       Impact factor: 3.633

3.  Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.

Authors:  David T Hughes; Matthew L White; Barbra S Miller; Paul G Gauger; Richard E Burney; Gerard M Doherty
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

4.  American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma.

Authors:  Tobias Carling; Sally E Carty; Maria M Ciarleglio; David S Cooper; Gerard M Doherty; Lawrence T Kim; Richard T Kloos; Ernest L Mazzaferri; Peter N Peduzzi; Sanziana A Roman; Rebecca S Sippel; Julie A Sosa; Brendan C Stack; David L Steward; Ralph P Tufano; R Michael Tuttle; Robert Udelsman
Journal:  Thyroid       Date:  2012-02-07       Impact factor: 6.568

5.  Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases.

Authors:  Giovanni Conzo; Daniela Pasquali; Giuseppe Bellastella; Katherine Esposito; Carlo Carella; Annamaria De Bellis; Giovanni Docimo; Michele Klain; Sergio Iorio; Salvatore Napolitano; Antonietta Palazzo; Alessandra Pizza; Antonio Agostino Sinisi; Emilia Zampella; Antonio Bellastella; Luigi Santini
Journal:  Endocrine       Date:  2013-01-19       Impact factor: 3.633

6.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

7.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.

Authors:  Mark Sywak; Lachlan Cornford; Paul Roach; Peter Stalberg; Stan Sidhu; Leigh Delbridge
Journal:  Surgery       Date:  2006-11-01       Impact factor: 3.982

8.  Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma.

Authors:  Dana M Hartl; Sophie Leboulleux; Abir Al Ghuzlan; Eric Baudin; Linda Chami; Martin Schlumberger; Jean-Paul Travagli
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

9.  Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.

Authors:  Stéphane Bonnet; Dana Hartl; Sophie Leboulleux; Eric Baudin; Jean D Lumbroso; Abir Al Ghuzlan; Linda Chami; Martin Schlumberger; Jean Paul Travagli
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

Review 10.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.

Authors:  Gregory W Randolph; Quan-Yang Duh; Keith S Heller; Virginia A LiVolsi; Susan J Mandel; David L Steward; Ralph P Tufano; R Michael Tuttle
Journal:  Thyroid       Date:  2012-10-19       Impact factor: 6.568

View more
  7 in total

1.  Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases.

Authors:  Pedro W Rosario; Gabriela F Mourão; Thassio L Siman; Maria R Calsolari
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

Review 2.  The role of surgery in the current management of differentiated thyroid cancer.

Authors:  Giovanni Conzo; Nicola Avenia; Giuseppe Bellastella; Giancarlo Candela; Annamaria de Bellis; Katherine Esposito; Daniela Pasquali; Andrea Polistena; Luigi Santini; Antonio Agostino Sinisi
Journal:  Endocrine       Date:  2014-04-10       Impact factor: 3.633

3.  Intraoperative ultrasonography is useful in surgical management of neck metastases in differentiated thyroid cancers.

Authors:  Burak Ertas; Hakan Kaya; Neslihan Kurtulmus; Abdullah Yakupoglu; Serdar Giray; Omer Faruk Unal; Mete Duren
Journal:  Endocrine       Date:  2014-05-27       Impact factor: 3.633

4.  Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?

Authors:  Hyun Joo Shin; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Kyung Hwa Han; Jin Young Kwak
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

5.  Endoscopic thyroidectomy along with bilateral central neck dissection (ETBC) increases the risk of transient hypoparathyroidism for patients with thyroid carcinoma.

Authors:  Dapeng Xiang; Liangqi Xie; Zhiyu Li; Ping Wang; Mao Ye; Mingzhu Zhu
Journal:  Endocrine       Date:  2016-02-17       Impact factor: 3.633

6.  Total thyroidectomy and central lymph node dissection. Experience of a referral centre for endocrine surgery.

Authors:  M Monacelli; R Lucchini; A Polistena; R Triola; C Conti; S Avenia; M S Di Patrizi; I Barillaro; A Boccolini; A Sanguinetti; N Avenia
Journal:  G Chir       Date:  2014 May-Jun

Review 7.  Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends.

Authors:  Giovanni Conzo; Ernesto Tartaglia; Nicola Avenia; Pier Giorgio Calò; Annamaria de Bellis; Katherine Esposito; Claudio Gambardella; Sergio Iorio; Daniela Pasquali; Luigi Santini; Maria Antonia Sinisi; Antonio Agostino Sinisi; Mario Testini; Andrea Polistena; Giuseppe Bellastella
Journal:  World J Surg Oncol       Date:  2016-05-17       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.